Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Use of stimulants in operational settings: Issues and considerations
Nicholas Davenport
, Cheryl Lowry
, Brian Pinkston
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of stimulants in operational settings: Issues and considerations'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Stimulants
100%
Operational Settings
100%
Circadian Rhythm
80%
Time Zones
80%
Department of Defense
60%
US Department of Defense
40%
Desynchronization
40%
HFACS
40%
Illness
20%
Causal Factors
20%
Amphetamine
20%
Adaptation
20%
Clinical Setting
20%
Physical Activity
20%
Military
20%
Excessive Daytime Sleepiness
20%
Narcolepsy
20%
Modafinil
20%
Attention Deficit Hyperactivity Disorder
20%
Healthy Adults
20%
Physiological Condition
20%
Classification System
20%
Aviation
20%
Task Performance
20%
Mental Capacity
20%
William Osler
20%
Biological Cycle
20%
Mishaps
20%
Rapid Movement
20%
Night Work
20%
Classification of Factors
20%
Shift Work Sleep Disorder
20%
Travel Direction
20%
Special Forces
20%
Jet Lag
20%
1 Introduction
20%
Mental Performance
20%
Extended Wakefulness
20%
Physical Capability
20%
Mental Activity
20%
Legitimate Uses
20%
Human Factors Analysis
20%
Biochemistry, Genetics and Molecular Biology
Circadian Rhythm
100%
Mental Performance
50%
Normal Human
25%
Physical Activity
25%
Wakefulness
25%
Modafinil
25%
Factor Analysis
25%
Task Performance
25%
Jet Lag
25%
Hyperactivity
25%
Neuroscience
Analeptic
100%
Circadian Rhythm
80%
Sleep Disorder
20%
Narcolepsy
20%
Modafinil
20%
Attention Deficit Hyperactivity Disorder
20%
Wakefulness
20%
Jet Lag
20%
Engineering
Department of Defense
100%
Ergonomics
20%
Force Unit
20%
Attention-Deficit Hyperactivity Disorder
20%
United States
20%
Jet
20%